These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 17016583)
1. Characterization of mitochondria in cisplatin-resistant human ovarian carcinoma cells. Hirama M; Isonishi S; Yasuda M; Ishikawa H Oncol Rep; 2006 Nov; 16(5):997-1002. PubMed ID: 17016583 [TBL] [Abstract][Full Text] [Related]
2. Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells. Andrews PA; Albright KD Cancer Res; 1992 Apr; 52(7):1895-901. PubMed ID: 1551118 [TBL] [Abstract][Full Text] [Related]
4. "Metabolic reprogramming" in ovarian cancer cells resistant to cisplatin. Montopoli M; Bellanda M; Lonardoni F; Ragazzi E; Dorigo P; Froldi G; Mammi S; Caparrotta L Curr Cancer Drug Targets; 2011 Feb; 11(2):226-35. PubMed ID: 21158717 [TBL] [Abstract][Full Text] [Related]
5. Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway. Yang X; Fraser M; Moll UM; Basak A; Tsang BK Cancer Res; 2006 Mar; 66(6):3126-36. PubMed ID: 16540663 [TBL] [Abstract][Full Text] [Related]
6. Differential regulation of the cytotoxicity activity of paclitaxel by orobol and platelet derived growth factor in human ovarian carcinoma cells. Isonishi S; Saitou M; Saitou M; Yasuda M; Tanaka T Oncol Rep; 2007 Jul; 18(1):195-201. PubMed ID: 17549368 [TBL] [Abstract][Full Text] [Related]
7. [Inhibition of mitochondrial Smac release by Akt in chemoresistant ovarian cancer cells]. Yang XK; Wang JD; Wang SY; Zhang YX Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):259-62. PubMed ID: 18788627 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells. Marzano C; Gandin V; Folda A; Scutari G; Bindoli A; Rigobello MP Free Radic Biol Med; 2007 Mar; 42(6):872-81. PubMed ID: 17320769 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells. Puca R; Nardinocchi L; Pistritto G; D'Orazi G Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248 [TBL] [Abstract][Full Text] [Related]
10. Enhancement of sensitivity to cisplatin by orobol is associated with increased mitochondrial cytochrome c release in human ovarian carcinoma cells. Isonishi S; Saitou M; Yasuda M; Ochiai K; Tanaka T Gynecol Oncol; 2003 Aug; 90(2):413-20. PubMed ID: 12893210 [TBL] [Abstract][Full Text] [Related]
11. [Effects of mifepristone on the proliferation, apoptosis, and cis-platinum (DDP) sensitivity of chemo-resistant human ovarian cancer cells]. Wang G; Zheng WT; Xiao P; Li XJ; Lin TC; Li GY Ai Zheng; 2004 Apr; 23(4):406-11. PubMed ID: 15087028 [TBL] [Abstract][Full Text] [Related]
12. Loss of cis-diamminedichloroplatinum(II) resistance in human ovarian carcinoma cells selected for rhodamine 123 resistance. Zinkewich-Péotti K; Andrews PA Cancer Res; 1992 Apr; 52(7):1902-6. PubMed ID: 1551119 [TBL] [Abstract][Full Text] [Related]
13. Mitochondria in platinum resistant cells. Isonishi S; Saitou M; Yasuda M; Tanaka T Hum Cell; 2001 Sep; 14(3):203-10. PubMed ID: 11774739 [TBL] [Abstract][Full Text] [Related]
14. Nuclear and mitochondrial distribution of organoamidoplatinum(II) lesions in cisplatin-sensitive and -resistant adenocarcinoma cells. Talarico T; Cullinane CM; Gray PJ; Webster LK; Deacon GB; Phillips DR Anticancer Drug Des; 2001; 16(2-3):135-41. PubMed ID: 11962511 [TBL] [Abstract][Full Text] [Related]
15. Expression of the cisplatin resistance phenotype in a human ovarian carcinoma cell line segregates with chromosomes 11 and 16. Mirakhur B; Parekh HK; Simpkins H Cancer Res; 1996 May; 56(10):2256-62. PubMed ID: 8625294 [TBL] [Abstract][Full Text] [Related]
16. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance. Brenes O; Arce F; Gätjens-Boniche O; Díaz C Biomed Pharmacother; 2007 Jul; 61(6):347-55. PubMed ID: 17399942 [TBL] [Abstract][Full Text] [Related]
17. Radiosensitivity in multidrug-resistant and cisplatin-resistant human carcinoma cell lines. Gigante M; Toffoli G; Bertola A; Biscontin G; Dassie A; Zanelli GD; Zanin E; Trovò MG; Muzzio PC Am J Clin Oncol; 2003 Aug; 26(4):e73-9. PubMed ID: 12902902 [TBL] [Abstract][Full Text] [Related]